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Extracellular nucleotides such as ATP and NAD can profoundly affect the functions of lymphocytes,
macrophages, and other cells. We have recently shown that extracellular NAD induces rapid apoptosis
in naive T cells by a mechanism involving the ADP-ribosylation of cell surface molecules. In the
present paper, we describe that T cells of different developmental stages differ in their sensitivity to
NAD-induced apoptosis. Thymocytes were less susceptible than peripheral lymph node T cells, and
freshly activated cells were more resistant than resting cells. Sensitivity to NAD-induced apoptosis
generally correlated with expression of the ADP-ribosyltransferase ART2.2, which is not expressed on
thymocytes and shed from peripheral T cells upon activation. Our ﬁndings suggest that NAD-induced
apoptosis does not play a role during thymic selection of T cells, but rather may play a role by
preventing the activation of unwanted bystander T cells during an immune response, and thus may
participate in the control of autoimmunity.
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INTRODUCTION
In order to survive, organisms must maintain a tight control
overthenumbersandreceptorspeciﬁcitiesofimmunecells.
The regulation of cell death and survival is central to this
task. Throughout their lifespan, T lymphocytes are
continually subject to processes that may result in their
death (van Parijs and Abbas, 1998). Regulated cell death
may result either from the withdrawal of survival signals
(death by neglect) or from the receipt of death signals
(actively induced cell death). A prototype of this latter
mechanism is the induction of apoptosis via signals
transmitted through the TNFR family of death receptors.
Wehaverecentlyreportedthatmicromolarconcentrationsof
extracellular NAD induce apoptosis in T cells via a
mechanism involving the ADP-ribosylation of cell surface
molecules (Adriouch et al., 2001). Besides the availability
of ecto-NAD, cell death in this model required the presence
of a cell surface mono(ADP-ribosyl)transferase (ART), as
well as one or more unknown downstream effector
molecules, presumably targets of ADP-ribosylation and/or
components of the signal transduction machinery.
ARTs post-translationally modify proteins by transfer-
ring an ADP-ribose moiety from NAD to speciﬁc amino
acids, e.g. arginine residues, of target proteins. ARTs have
well-characterized regulatory functions in the prokaryotic
world (Ludden, 1994). Several prokaryotic ARTs are
secreted and function as toxins that exert potent effects on
mammalian cells by inactivating key proteins in their
target cells (Koch-Nolte and Haag, 1997). In mammals, a
family of toxin-related extracellular ARTs has been
identiﬁed that are expressed either as GPI-anchored or
secreted molecules by different cell types (Koch-Nolte
and Haag, 1997; 1998; Glowacki et al., 2002).
ARTs have been implicated in T cell differentiation and
the regulation of immune function. Rat ART2, formerly
known as RT6, is a marker for mature T cells (Thiele et al.,
1997). A subset of ART2þ T cells exerts a regulatory
function in the BB rat model for autoimmune diabetes
mellitus (Greiner et al., 1986; 1987). T cells from
diabetes-prone BB rats show reduced expression of ART2,
and transfer of ART2þ T cells from diabetes-resistant
rats prevents the disease. The mouse carries two Art2
genes, and, as in the rat, expression of the corresponding
gene products, ART2.1 and ART2.2, is restricted to
mature T cells (Prochazka et al., 1991; Koch-Nolte et al.,
1999). NAD-dependent ADP-ribosylation of cell surface
proteins has been shown to inhibit the proliferation
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(Wang et al., 1994; 1996), and to inhibit proliferation
(Okamoto et al., 1998) and induce apoptosis (Adriouch
et al., 2001; Liu et al., 2001) in primary T cells.
In this report, we examine the susceptibility of T cells of
different developmental stages to NAD-induced apoptosis.
Based on the ﬁnding that mature resting T cells represent
the cell population most sensitive to NAD-induced cell
death, the hypothesis is presented that ART-mediated cell
death could play a role in the control of autoimmunity by




Chemicals were from Sigma (Deisenhofen, Germany).
AnnexinV-FITC, anti-CD3-PE, anti-rat-Ig-PE, and anti-
CD3-, -CD28-, and -CD95-antibodies were from
Pharmingen (Heidelberg, Germany). ART2.2-speciﬁc
antibody Nika102 has been described (Koch-Nolte et al.,
1999).
Animals and Preparation of Cells
Six to eight week-old BALB/cByJ mice were obtained
from Charles River (Sulzfeld, Germany). Thymi and
lymph nodes were isolated from sacriﬁced animals, and
single cell suspensions were prepared and processed for
ﬂow cytometry on a FACScan (Becton Dickinson) as
described previously (Adriouch et al., 2001). Where
indicated, T cells were enriched by depletion of B cells
using magnetic cell separation with Dynabead-immobi-
lized goat anti-mouse IgG (Dynal, Hamburg, Germany,
4–6 beads/cell).
Assay for Phosphatidylserine (PS) Exposure
Apoptotic and necrotic cells were stained with AnnexinV-
FITC and propidium iodide essentially as described
previously (Adriouch et al., 2001). In brief, following
treatment with the indicated concentrations of extra-
cellular ATP or bzATP at 378C, cells were washed in
RPMI medium supplemented with 2mM CaCl2, and
were then stained in this medium for 20min on ice with
FITC-conjugated AnnexinV (1mg/ml) and propidium
iodide (10mg/ml) or PE-conjugated anti-mouse IgG.
RESULTS
Ecto-NAD Induces Rapid Apoptosis of T Cells by a
Mechanism Involving ADP-ribosylation
In a previous report, we showed that treatment with
extracellular NAD induces rapid T cell death by apoptosis
(Adriouch et al., 2001). This is evidenced ﬁrst by exposure
of PS on the outer leaﬂet of the plasma membrane,
by failure to exclude propidium iodide (Fig. 1a), and
ultimately by fragmentation of DNA (Adriouch et al.,
2001). Induction of apoptosis by NAD is rapid, as
PS-exposure evidenced by AnnexinV staining was
observed as early as 0.5min after exposure to NAD
(Fig. 1b).
Thymocytes and Peripheral T Cells Differ in
Sensitivity to NAD-induced and CD95-mediated
Apoptosis
To examine the sensitivity of T cells at different stages of
development to ecto-NAD-induced apoptosis, thymocytes
and peripheral lymph node cells were incubated for 2h
with different concentrations of NAD or with 2mg of anti-
CD95 antibody, and assayed for PS exposure by
AnnexinV staining (Fig. 2). Lymph node cells responded
to ecto-NAD in a dose-dependent manner, but were
resistant to treatment with anti-CD95 antibody. Thymo-
cytes, by contrast, became AnnexinV-positive in response
to anti-CD95, but remained resistant to the effects of even
100mM ecto-NAD. Concomitant staining for AnnexinV-
binding and expression of CD3 showed that among
FIGURE 1 Extracellular NAD induces rapid phosphatidylserine
exposure and cell death in T lymphocytes. Puriﬁed lymph node T cells
were incubated with the indicated concentrations of NAD at 378C for 2h
(a) or the indicated times (b) before staining with annexinV-FITC and
propidium iodide.
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ecto-NAD-induced apoptosis. In the thymus, neither
immature CD3lo nor the more mature CD3hi cells
responded to ecto-NAD, while CD95-mediated apoptosis
was observed within the CD3lo population (Fig. 2b).
Activated T Cells Shed ART2 and Show Decreased
Sensitivity to Ecto-NAD-induced Apoptosis
We have previously reported that T cells release cell
surface ART2 upon stimulation with PMA by a
metalloproteinase-mediated mechanism (Kahl et al.,
2000). To examine whether T cells also become resistant
to NAD-induced apoptosis upon activation, puriﬁed
lymph node T cells were incubated for 2h with polyclonal
T-cell stimulators before treatment with NAD. Treatment
with either phorbol myristate acetate (PMA) or a
combination of anti-CD3 and anti-CD28 antibodies
caused a marked reduction in the level of cell surface
ART2.2 compared to untreated cells (Fig. 3a). In addition,
both treatments also led to increased resistance to NAD-
induced apoptosis, as evidenced by reduced staining with
AnnexinV and propidium iodide compared to control cells
(Fig. 3b).
DISCUSSION
The maintenance of homeostasis in the immune system
and the focusing of immune reactions on appropriate
targets require the coordinated interplay of regulatory
mechanisms, many of which involve programmed cell
death (van Parijs and Abbas, 1998). We have recently
identiﬁed a new death signal for lymphocytes: the
exposure to extracellular NAD (Adriouch et al., 2001).
Aim of the present study was to examine the sensitivity of
T cells to NAD-induced apoptosis during different stages
of development.
In naive peripheral T cells, exposure to ecto-NAD
causes exposure of PS and permeabilization to propidium
iodide. PS-exposure, as evidenced by AnnexinV-binding,
is an early indicator of apoptosis in many cell types
(Bossy-Wetzel and Green, 2000) although it has been
reported to be reversible in some cases (MacKenzie et al.,
2001). In naive peripheral T cells, PS exposure is followed
by failure to exclude PI and ultimately by fragmentation of
DNA (Adriouch et al., 2001), indicating that these cells
indeed have progressed to cell death. NAD-induced
apoptosis is rapid, since PS exposure was detected as
early as 0.5min following treatment with NAD. Several
lines of evidence suggest that the pro-apoptotic effects of
NAD are mediated via the ADP-ribosylation of cell
surface molecules. First, among peripheral lymphocytes
those cells expressing the T cell-speciﬁc ADP-ribosyl-
transferase ART2 are most susceptible to NAD-induced
apoptosis (Adriouch et al., 2001). Further, treatment of
cells with phosphatidylinositol-speciﬁc phospholipase
C (PI-PLC), which removes glycosyl-phosphatidyl-
inositol- (GPI-) anchored ART2 from the cell surface,
renders cells resistant to NAD-induced apoptosis
FIGURE 2 Differential sensitivity of thymocytes and lymph node cells to NAD and anti-CD95 antibodies. Thymocytes and total lymph node cells
were incubated for two hours at 378C with NAD or anti-CD95 antibodies before staining with annexinV-FITC and propidium iodide (a) or anti-CD3
antibodies (b).
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apoptosis can be blocked by antibodies against ART2
(Adriouch et al., 2001). Finally, activation of T cells,
which induces shedding of ART2 (Kahl et al., 2000),
correlates with increased resistance to NAD-induced
PS-exposure.
T cells are susceptible to programmed cell death at all
stages of their development. In the thymus, regulation of
apoptosis in the context of positive and negative selection
of thymocytes is important for the shaping of the T cell
repertoire. In the periphery, resting T cells depend on
survival signals for their maintenance. After activation,
withdrawal of survival signals and activation-induced
cell death (AICD) serve to reduce lymphocyte numbers
during thewaning of an immune response and to eliminate
auto-reactive T cells. Here, we examined the differential
sensitivity of thymocytes as well as resting and activated
T cells to NAD-induced apoptosis and compared the
effects of NAD to a classical “active” death signal,
triggering of the CD95 receptor by anti-CD95 antibodies.
The results show that mature resting T cells represent the
population most susceptible to NAD-induced apoptosis,
while thymocytes are completely, and activated lymph
node T cells partially resistant. Thus, susceptibility to
FIGURE 3 Activated T cells shed ART2.2 and become resistant to NAD-induced apoptosis. Puriﬁed lymph node T cells were incubated for 2 h at
378C with 100ng/ml PMA or 1mg/ml plate-bound anti-CD3/CD28 antibodies. (a) Expression of ART2.2 was analyzed by staining with Nika102
followed by anti-rat-Ig-PE. Untreated cells are represented by the shaded histogram, PMA- and anti-CD3-treated cells by bold and dotted lines,
respectively. (b) Cells as in (a) were treated for 30min at 378C with the indicated concentrations of NAD before staining with annexinV-FITC and
propidium iodide.
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(Koch-Nolte et al., 1999). This enzyme is expressed on the
surface of mature T cells and shed from the surface of
activated T cells by the action of a metalloproteinase
(Kahl et al., 2000). Interestingly, NAD-induced
apoptosis does not occur within the population of mature
CD3hi thymocytes, a portion of which express ART2
(Koch-Nolte et al., 1999). This may be due to the absence
in these cells of a downstream effector, which previous
studies have shown to be necessary for ART-mediated
apoptosis (Adriouch et al., 2001). Resting peripheral
T cells were completely resistant to CD95-mediated
apoptosis under the conditions employed in our
experiments. This presumably reﬂects a requirement for
pre-activation in these cells for the assembly of the
death-inducing signaling complex (DISC), necessary for
the transduction of death signals via CD95. By contrast,
apoptosis was readily visible within the immature CD3lo
population of thymocytes, reﬂecting the importance of
CD95 for thymocyte selection (Debatin et al., 1994;
Anderson et al., 1996). What may be the biological role
of NAD-induced cell death? Our results indicate that
ART-mediated apoptosis does not contribute to thymic
selection, but rather suggest that the importance of ecto-
NAD as a death signal lies within the peripheral T cell
compartment. Extracellular NAD differs from other
“active” death signals in several respects. First of all,
it induces the exposure of PS more rapidly than signaling
via death receptors. Secondly, ecto-NAD as a death signal
within the immune system is unique in that it selectively
affects mature resting T cells. As discussed above,
expression of ART2 is a pre-requisite for NAD-induced
apoptosis. Naturally occurring deﬁciencies of ART2
(formerly designated Rt6) have been observed in several
mouse and rat models for autoimmune diseases. It is thus,
an attractive hypothesis that ecto-NAD-induced cell
death contributes to the prevention of autoimmunity.
We propose that this occurs by eliminating unwanted
bystander cells that may become activated in the course of
an immune reaction (Fig. 4). Under physiological
conditions the concentration of extracellular NAD is
low, i.e. in the nanomolar range. Micromolar concen-
trations of extracellular NAD, which are sufﬁcient to
trigger NAD-induced cell death, may be expected to occur
either as a result of local tissue injury, as happens during
inﬂammation, or as the result of regulated secretion
mechanisms (Bruzzone et al., 2001). In the scenario of an
immune reaction against a pathogen, antigen-speciﬁc
activated T effector cells, which themselves have shed cell
surface ARTs and thus are resistant to NAD-induced cell
death (Fig. 4a), cause the lysis of target cells, thereby
releasing NAD into the extracellular compartment
(Fig. 4b). Resting bystander cells, which are not speciﬁc
for the pathogen, but which might become activated due to
the multitude of stimulatory signals generated during the
inﬂammatory response, would be eliminated following
exposure to NAD and ART2-catalyzed ADP-ribosylation
of cell surface target proteins (Fig. 4c).
In conclusion, ecto-NAD-induced cell death provides a
novel mechanism of focusing an apoptotic signal to a
selected population of cells which express appropriate
“receptor” molecules that are able to process the signal.
These molecules include the ARTs, but also one or more
as yet unknown effector molecules that are targets for
ADP-ribosylation. It will be a challenge to identify
these downstream effectors, and to determine whether
NAD-induced cell death also operates outside of the
immune system.
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